Keng-Li Lan

Inverse Agonist Activity at the α_2A-Adrenergic Receptor

Susan M. Wade, Keng-Li Lan, Dorian J. Moore et al. · Molecular Pharmacology · 2001 · 49 citations

Life Sciences, Biochemistry, Pharmacology +17

188Re-Liposome Can Induce Mitochondrial Autophagy and Reverse Drug Resistance for Ovarian Cancer: From Bench Evidence to Preliminary Clinical Proof-of-Concept

Chia‐Ming Chang, Keng-Li Lan, Wen-Sheng Huang et al. · International Journal of Molecular Sciences · 2017 · 48 citations · Full text

Medicine, Oncology, Pharmacology +17

A phase 0 study of the pharmacokinetics, biodistribution, and dosimetry of 188Re-liposome in patients with metastatic tumors

Shyh-Jen Wang, Wen-Sheng Huang, Chi-Mu Chuang et al. · EJNMMI Research · 2019 · 30 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Antiviral effect of saikosaponin B2 in combination with daclatasvir on NS5A resistance-associated substitutions of hepatitis C virus

Wei-Ping Lee, Keng-Li Lan, Shi-Xian Liao et al. · Journal of the Chinese Medical Association · 2019 · 24 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Comparative Therapeutic Efficacy of Rhenium-188 Radiolabeled-Liposome and 5-Fluorouracil in LS-174T Human Colon Carcinoma Solid Tumor Xenografts

Chin-Wei Hsu, Ya‐Jen Chang, Chih-Hsien Chang et al. · Cancer Biotherapy and Radiopharmaceuticals · 2012 · 18 citations

Medicine, Pharmacokinetics, Pharmacology +17